Prominent Drug Chief to Sell Abraxis BioScience to Celgene for $2.9 Billion - New York Times

RTT News
Prominent Drug Chief to Sell Abraxis BioScience to Celgene for $2.9 Billion
New York Times
He has been sued by business partners, including his brother. Some scientists accused him of exaggerating the effectiveness of a diabetes treatment he ...
Biotech's Soon-Shiong Nabs Another BillionForbes (blog)
Ryan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc.MarketWatch (press release)
Tripp Levy PLLC Investigates Buyout of Abraxis BioSciencesMarketWatch (press release)
MarketWatch (press release) -Wall Street Journal -BusinessWeek
all 661 news articles »